☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Pliant Therapeutics
Pliant Therapeutics Reports Results of P-IIa (INTEGRIS-PSC) Trial for the Treatment of Primary Sclerosing Cholangitis and Suspecte...
February 5, 2024
Pliant Therapeutics Reports an Initiation of P-IIb Trial (BEACON-IPF) for Bexotegrast to Treat Idiopathic Pulmonary Fibrosis
August 10, 2023
Load more...
Back to Home
Modal title
×
Modal body text goes here.